307 related articles for article (PubMed ID: 21370433)
1. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
2. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
4. Pediatric liver transplantation for hepatoblastoma: a single center experience.
Kim T; Kim DY; Kim KM; Seo JJ; Park KM; Lee YJ; Lee SG
Transplant Proc; 2012 Mar; 44(2):523-5. PubMed ID: 22410061
[TBL] [Abstract][Full Text] [Related]
5. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.
De Ioris M; Brugieres L; Zimmermann A; Keeling J; Brock P; Maibach R; Pritchard J; Shafford L; Zsiros J; Czaudzerna P; Perilongo G
Eur J Cancer; 2008 Mar; 44(4):545-50. PubMed ID: 18166449
[TBL] [Abstract][Full Text] [Related]
6. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
[TBL] [Abstract][Full Text] [Related]
8. Features predicting unresectability in hepatoblastoma.
D'Antiga L; Vallortigara F; Cillo U; Talenti E; Rugge M; Zancan L; Dall'Igna P; De Salvo GL; Perilongo G
Cancer; 2007 Sep; 110(5):1050-8. PubMed ID: 17661341
[TBL] [Abstract][Full Text] [Related]
9. Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
Sayar D; Yaniv I; Goshen Y; Cohen IJ
Pediatr Hematol Oncol; 2001 Dec; 18(8):509-18. PubMed ID: 11764100
[TBL] [Abstract][Full Text] [Related]
10. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and outcome of 14 children with hepatoblastoma].
Wei T; Yang TQ; Luo YG; Dong CQ
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):456-9. PubMed ID: 19558810
[TBL] [Abstract][Full Text] [Related]
12. Successful liver transplant for unresectable hepatoblastoma.
Casas-Melley AT; Malatack J; Consolini D; Mann K; Raab C; Flynn L; Woolfrey P; Menendez J; Dunn SP
J Pediatr Surg; 2007 Jan; 42(1):184-7. PubMed ID: 17208562
[TBL] [Abstract][Full Text] [Related]
13. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Kanke F; Satomura S
Cancer Sci; 2011 May; 102(5):1025-31. PubMed ID: 21244578
[TBL] [Abstract][Full Text] [Related]
15. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
Masuda T; Beppu T; Horino K; Komori H; Hayashi H; Okabe H; Otao R; Horlad H; Ishiko T; Takamori H; Kikuchi K; Baba H
J Surg Oncol; 2010 Oct; 102(5):490-6. PubMed ID: 19937994
[TBL] [Abstract][Full Text] [Related]
16. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
17. Review of outcomes of primary liver cancers in children: our institutional experience with resection and transplantation.
Malek MM; Shah SR; Atri P; Paredes JL; DiCicco LA; Sindhi R; Soltys KA; Mazariegos GV; Kane TD
Surgery; 2010 Oct; 148(4):778-82; discussion 782-4. PubMed ID: 20728194
[TBL] [Abstract][Full Text] [Related]
18. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
von Schweinitz D; Bürger D; Bode U; Weinel P; Erttmann R; Hecker H; Mildenberger H
Klin Padiatr; 1994; 206(4):282-8. PubMed ID: 7526028
[TBL] [Abstract][Full Text] [Related]
19. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of primary liver cancer in children: an appraisal of experience.
Pham TH; Iqbal CW; Grams JM; Zarroug AE; Wall JC; Ishitani MB; Nagorney DM; Moir C
J Pediatr Surg; 2007 May; 42(5):834-9. PubMed ID: 17502194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
